Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “combination”

418 pharma patents match "combination" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 418
Index total 30,257
Page 15 / 18

Quick answer

This filtered view shows 418 pharmaceutical patents matching "combination" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

418 results for “combination” · 30,257 patents in full index Clear search

  1. US 8809268

    Combination therapy to combat helminth resistance

    The Regents of the University of California · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  2. US 8790652

    Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis

    VACCINEX, INC. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  3. US 8778391

    Flurbiprofen and muscle relaxant combinations

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  4. US 8728458

    Combination anti-HIV vectors, targeting vectors, and methods of use

    The Regents of the University of California · Granted May 20, 2014 · Expires May 15, 2034

    granted

  5. US 8709417

    Combination immunotherapy for the treatment of cancer

    BOARD OF REGENTS · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  6. US 8691778

    Flurbiprofen and muscle relaxant gel combinations thereof

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  7. US 8673964

    Use of drug combinations for treating insulin resistance

    DiaMedica Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  8. US 8663602

    Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  9. US 8658627

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  10. US 8637026

    Anti-C35 antibody combination therapies and methods

    VACCINEX, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  11. US 8637074

    Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product

    Aphios Corporation · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  12. US 8633178

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  13. US 8614179

    Antibacterial combination therapy for the treatment of gram positive bacterial infections

    E-Therapeutics PLC · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  14. US 8580844

    Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

    Georgia Regents Research Institute, Inc. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  15. US 8546433

    Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer

    Rigel Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  16. US 8524500

    Methods and compositions for targeted cleavage and recombination

    Sangamo Biosciences, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  17. US 8501766

    Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  18. US 8501713

    Drug combinations for the treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  19. US 8486923

    Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

    TAKEDA GMBH · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  20. US 8481529

    Combination cancer chemotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  21. US 8435497

    Formoterol of and ciclesonide combination

    TAKEDA GMBH · Granted May 7, 2013 · Expires May 2, 2033

    granted

  22. US 8415384

    Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade

    The Board of Regents of the University of Texas System · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  23. US 8394377

    Methods for treating cancer using combination therapy

    The Regents of the University of Colorado · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  24. US 8388963

    Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.